| Entire group | Survivors | Nonsurvivors | |
| Subjects | 90 (100) | 62 (69) | 28 (31) |
| Age yrs | 59±12 | 58±14 | 58±15 |
| Males | 47 (52) | 29 (47) | 18 (64) |
| Creatinine μmol·L−1 | 88.5±26.2 | 87.7±26.0 | 91.9±27.3 |
| Pulmonary function | |||
| DL,CO % pred | 38.0±15.9 | 39.7±16.6 | 34.0±13.7 |
| FVC % pred | 75.3±22.3 | 78.6±21.9* | 68.1±21.7* |
| TLC % pred | 77.1±19.8 | 79.3±20.2 | 71.7±18.1 |
| Pa,O2 kPa | 9.2±2.3 | 9.5±2.9 | 8.5±2.0 |
| 6-min walk test# | |||
| End test Sp,O2 % | 83.3±8.8 | 84.2±9.1 | 82.5±9.3 |
| 6-min walk distance m | 271±127 | 277±130 | 258±123 |
| Brain natriuretic peptide pmol·L−1 | 11 (1.4–377) | 9 (3–193.8)¶ | 22 (1.4–377)¶ |
| Echocardiography | |||
| RVSP mmHg+ | 49.9±21.7 | 46.9±21.3* | 59.2±19.1* |
| RAP mmHg | 8.3±3.9 | 8.0±4.1 | 8.8±3.4 |
| Pulmonary acceleration time ms | 96.8±26.9 | 109.3±32.3 | 102.2±31.2 |
| Fractional shortening % | 36.8±9.2 | 37.6±9.8 | 35.1±7.9 |
Data are presented as n (%), mean±sd or median (range). DL,CO: diffusing capacity of the lung for carbon monoxide; % pred: % predicted; FVC: forced vital capacity; TLC: total lung capacity; Pa,O2: arterial oxygen tension; Sp,O2: arterial oxygen saturation measured by pulse oximetry; RVSP: right ventricular systolic pressure; RAP: right arterial pressure. #: n = 55; +: n = 63. *: p<0.05 (unpaired t-test); ¶: p<0.05 (Wilcoxon's rank sum test).